Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature

Infection following SARS‐Co V‐2 leading to COVID‐19 disease is associated with significant morbidity and mortality. The clinical entity, COVID‐19 cytokine storm syndrome (CSS) is a severe immunological manifestation of the disease associated with ominous consequences. Tocilizumab is interleukin‐6 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Bishawi, Ahmad, Abdalla, Shiema, Askar, Marwa, Kanjo, Wael, Sameer, Amal, Mustafa, Gihan, Abdel Hadi, Hamad, Al Maslamani, Muna, Abdelmajid, Alaaeldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136592/
https://www.ncbi.nlm.nih.gov/pubmed/35664523
http://dx.doi.org/10.1002/ccr3.5932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136592/
https://www.ncbi.nlm.nih.gov/pubmed/35664523
http://dx.doi.org/10.1002/ccr3.5932

Ejemplares similares